Latest Regulatory News

Novonix has secured A$20.7 million from an institutional placement at a 33% discount, alongside a A$3 million Share Purchase Plan for existing shareholders, aiming to fund production capacity expansion amid growing battery demand.

Golden Dragon Mining has applied for a new tenement just 1.5 km from Westgold’s Big Bell Gold Mine, extending its landholding in Western Australia’s Murchison Goldfields to about 619 km². The move boosts exposure to a prolific gold belt with multiple high-priority targets, including the drill-ready Jeffrey Well prospect.

Resources & Energy Group (ASX:REZ) has locked in a binding term sheet with Rembrandt Mining to kickstart gold production at its Maranoa deposit, preserving full ownership while shifting capital risk to Rembrandt and capturing enhanced profit shares at higher gold prices.

Bougainville Copper Limited has been officially notified that its Exploration Licence No. 01 is suspended following the Bougainville Executive Council’s approval of a 25-year Large-Scale Mining Lease granted to Bougainville Minerals Limited over the same land.

ABx Group has confirmed its second mixed rare earth carbonate sample from Tasmania’s Deep Leads deposit exhibits even lower radioactivity than the first, reinforcing its exemption from radiological control and attracting positive feedback from key customers.

International Graphite Ltd (ASX:IG6) has partnered with Alkeemia S.p.A. to establish a graphite processing facility in Italy, aiming for first production in the second half of 2027 and a final investment decision by Q3 2026.

Iron Bear Resources (ASX:IBR) has detailed progress on its Canadian Iron Bear Project, highlighting a robust scoping study, a major joint venture with Vale, and strategic advantages in a growing direct reduction pellet market.

Zinc of Ireland (ASX: ZMI) has finalised its acquisition of Meclex, securing two hydrometallurgical technologies aimed at disrupting zinc and lead processing with low-emission methods. Backed by a fresh A$5.5 million placement, ZMI is accelerating pilot plant development and exploration at its Kildare project.

Neurizon Therapeutics has secured a critical five-year supply agreement with Elanco Animal Health for GMP-grade monepantel, underpinning the commercialisation readiness of its lead ALS drug candidate NUZ-001.

Island Pharmaceuticals has won a key regulatory boost as the US FDA granted Orphan Drug Designation to Galidesivir for post-exposure prophylaxis of Marburg virus disease, enhancing its commercial and development prospects.

Lithium Universe (ASX: LU7) has completed the detailed process flow sheet for a novel hydrometallurgical technology licensed from the University of Edinburgh to extract gold and copper from electronic waste. The low-temperature, reagent-recycling method aims to disrupt traditional smelting with environmental and cost benefits.

Sweden's Parliament has amended legislation to remove uranium mining from nuclear facility regulations, simplifying permits and strengthening Aura Energy's prospects for its Häggån uranium deposit.